- Center on Health Equity and Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Talks of Higher Medicaid Pay from Capitol Hill
Although states control Medicaid payment rates, federal government members agree that providers need higher reimbursements. MedPage Today reports:
Rep. Henry Waxman (D-Calif.), the top Democrat on the House Energy and Commerce Committee, suggested Wednesday that Congress do one thing that can be done from Washington: extend the temporary payment increase Medicaid primary care providers are seeing, bringing their reimbursements on par with those of Medicare. The change impacts general pediatricians, general internists, and family physicians.
The Affordable Care Act allowed for this bump in pay for 2013 and 2014 with the federal government paying the difference, but Waxman suggested it be extended beyond next year. "Any member concerned about access to doctors for Medicaid beneficiaries should surely embrace that," he said.
Medicaid on average pays 66% of Medicare rates, Seema Verma, MPH, a health policy consultant with Strategic Health Policy Solutions in Carmel, Ind., told lawmakers at the committee hearing, entitled "The Need for Medicaid Reform."
Read the full story here: http://bit.ly/160p6R6
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Navigating Health Literacy, Social Determinants, and Discrimination in National Health Plans
February 13th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the February 2024 issue of The American Journal of Managed Care® about their findings on how health plans can screen for health literacy, social determinants of health, and perceived health care discrimination.
Listen
Polatuzumab Vedotin and R-CHP Appropriate for Untreated DLBCL
April 24th 2024Population pharmacokinetic and exposure-response analyses revealed a favorable benefit-risk profilane for the treatment combination of polatuzumab vedotin and rituximab, cyclophosphamide, doxorubicin, and prednisone (R-CHP).
Read More
Drs Raymond Thertulien, Joseph Mikhael on Racial Disparities in Multiple Myeloma Care Access
December 28th 2023In the wake of the 2023 American Society of Hematology Annual Meeting and Exposition, Raymond Thertulien, MD, PhD, of Novant Health, and Joseph Mikhael, MD, MEd, FRCPC, FACP, chief medical officer of the International Myeloma Foundation, discussed health equity research highlights from the meeting and drivers of racial disparities in multiple myeloma outcomes.
Listen
Award-Winning Poster Presentations From AMCP 2024
April 23rd 2024At the Academy of Managed Care Pharmacy (AMCP) 2024 annual meeting, multiple poster presentations concerned with health equity, data collection, glucagon-like peptide-1 agonists, and more were acknowledged for their originality, relevance, clarity, bias, and quality.
Read More
